According to the Graphical Research new growth forecast report titled “Asia Pacific Microsurgery Robot Market Size By Application (Ophthalmology Surgery, Cardiovascular Surgery, Neurovascular Surgery, Gastrointestinal Surgery, Obstetrics and Gynecology Surgery, Urology Surgery, Oncology Surgery, ENT Surgery, Reconstructive Surgery, Micro Anastomosis, Ureterorenoscopy), By End-use (Hospitals and Clinics, Ambulatory Surgical Centers, Research Institutes), Industry Analysis Report, Regional Outlook (China, Japan, India, Australia, South Korea, Indonesia, Thailand, Taiwan, Malaysia)”, Estimated To Cross USD 460 Million By 2027
Surging demand for computer-integrated surgery (CIS) will propel the APAC microsurgery robot market growth. CIS involves the use of surgical robots in automation and imaging of procedures. For instance, surgical robots are involved in image processing to provide 3D visualization and improved magnification of surgical sites. Furthermore, they can be used in automation of tissue ablation in routine procedures. CIS also involves the use of computer aided design and manufacturing (CAD/CAM). This provides digital information that can be used in generating precise representations and surgical plans. This greatly improves patient outcomes and eliminates errors. The imaging allows a surgeon to greatly personalize the surgery based on the patient models provided by surgical robots. In addition, the robots register preoperative information of the patient in the operating room and uses variations of resources, such as image displays to support precise execution of interventions. Hence, several above-mentioned factors proves favorable for the overall industry progression.
On the basis of application, the APAC microsurgery robot market is divided into obstetrics and gynecology surgery, cardiovascular surgery, gastrointestinal surgery, ophthalmology surgery, neurovascular surgery, oncology surgery, ENT surgery, urology surgery, micro anastomosis, reconstructive surgery, and ureterorenoscopy among others. The obstetrics and gynecology surgery segment accounted for more than USD 23 million revenue size in 2020. Rising number of gynecological surgeries in Asia Pacific region coupled with improved outcomes due to enhanced robotic surgeries will drive the overall segmental growth. Various advantages including reduced hospital stays, minimum blood loss and improved dexterity will surge the demand for microsurgery robots.
Based on end-use, the APAC microsurgery robot market is classified into hospitals and clinics, ambulatory surgical centers, research institutes and others. Amongst them, the ambulatory surgical centers segment captured around 28% market share in 2020. The increasing preference towards ambulatory surgical centers is increasing significantly in Southeast Asian countries including Thailand and Malaysia, augmenting the market growth. Rising demand for advanced robotic-assisted systems in ambulatory surgical centers for effective patient treatment will enhance the segmental progression. Availability of well-developed infrastructure and skilled healthcare professionals in ambulatory surgical centers will further favor the business growth.
The India microsurgery robot market accounted for around 16.5% CAGR over the analysis timeframe. Numerous microsurgery robotic devices have been installed at various government and private hospitals in India. Number of installations is expected to rise significantly in the foreseeable future, offering surgeons and patients with an alternative to traditional techniques, enhancing the business growth. Additionally, there is an increased interest from both private and public hospitals to adopt robotic-assisted surgery, creating positive impact on the country growth.
Some of the well-known business players operating in the APAC microsurgery robot market are Zimmer Biomet, Intuitive Surgical, Stryker, Medrobotics Corporation, Corindus Inc (Siemens Healthineers), Auris Health (Johnson & Johnson), Smith & Nephew, Medtronic, and TransEnterix Surgical. These prominent business players have undertaken different growth strategies for maintaining resilient foothold in microsurgery robot market. For instance, in May 2018, Auris Health announced its collaboration with Neuwave Medical, a subsidiary of Ethicon for development of innovative and advanced robotic systems. This collaboration has enabled the company to expand its product portfolio and launch new and technologically advanced products.
APAC microsurgery robot market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2016 to 2027, for the following segments:
APAC Microsurgery Robot Market, By Application, 2016 - 2027 (USD Million)
o Ophthalmology Surgery
o Cardiovascular Surgery
o Neurovascular Surgery
o Gastrointestinal Surgery
o Obstetrics and gynecology surgery
o Urology Surgery
o Oncology Surgery
o ENT Surgery
o Reconstructive Surgery
o Micro anastomosis
APAC Microsurgery Robot Market, By End-use, 2016 - 2027 (USD Million)
o Hospitals and clinics
o Ambulatory surgical centers
o Research institutes
The above information is provided for the following region and countries:
o Asia Pacific
o South Korea